 death rates in all
recent clinical trials have been achieved with this combination therapy.9,10,162,163 Dual-antiplatelet therapy should

patients compliant with aspirin therapy may still develop
atherothrombotic complications, such as stroke. Reduced
antiaggregant effect is more common in patients taking
lower-dose aspirin (81 mg) or 325 mg aspirin with an
enteric coating than it is in patients